目的 系统评价人类白细胞抗原B(human leukocyte antigen B，HLA-B)基因多态性与抗癫痫药拉莫三嗪致皮肤不良反应(lamotrigine-cutaneous adverse reactions，LTG-cADRs)的相关性。方法 通过计算机全面检索中国期刊全文数据库、万方数字化期刊全文库、中国科技期刊全文数据库、PubMed、Web of Science、Science Direct数据库，检索时间截至2022年7月15日，采用RevMan5。4软件进行meta分析。结果 共纳入16篇病例对照研究，331例LTG-cADRs癫痫患者，其中94例拉莫三嗪致史-约综合征/中毒性表皮坏死松懈症(lamotrigine-Stevens-Johnson syndrome/toxic epidermal necrolysis，LTG-SJS/TEN)患者，232 例拉莫三嗪致斑丘疹(lamotrigine-maculopapule，LTG-MPE)患者，5 例伴嗜酸粒细胞增多和系统症状的药疹(lamotrigine-drug rash with eosinophilia and systemic symptoms，LTG-DRESS)患者;612 例拉莫三嗪耐受癫痫患者。Meta分析结果显示:HLA-B*1502等位基因与LTG-SJS/TEN存在显著相关性(OR=3。03，95％CI:1。70～5。39，P=0。000 2)。HLA-B*1502、HLA-B*5801、HLA-B*1302 等位基因均与 LTG-MPE 无显著相关性。结论 HLA-B*1502等位基因与LTG-SJS/TEN存在相关性，可能是LTG-SJS/TEN风险基因;HLA-B*1502、HLA-B*5801和HLA-B*1302等位基因与LTG-MPE无相关性。
Meta-analysis of Association Between HLA-B Gene Polymorphism and Antiepileptic Lamotrigine-induced Cutaneous Adverse Drug Reactions
OBJECTIVE To systematically evaluate the association between human leukocyte antigen B(HLA-B)gene polymorphisms and lamotrigine-induced cutaneous adverse drug reactions(LTG-cADRs).METHODS CNKI,Wanfang Data,VIP,PubMed,Web of Science,Science Direct were comprehensively searched from the inception to July 15,2022.The software RevMan 5.4 was used for the meta-analysis.RESULTS A total of 16 case-control studies were included,331 patients with LTG-cADRs epilepsy,including 94 lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis(LTG-SJS/TEN)patients,232 lamotrigine-maculopapule(LTG-MPE)patients and 5 lamotrigine-drug rash with eosinophilia and systemic symptoms(LTG-DRESS)patients;612 lamotrigine-tolerant patients.Meta-analysis results showed that the HLA-B*1502 allele was significantly associated with LTG-SJS/TEN(OR=3.03,95％CI:1.70-5.39,P=0.000 2).The HLA-B*1502,HLA-B*5801,HLA-B*1302 alleles were not significantly associated with LTG-MPE.CONCLUSION HLA-B*1502 allele is associated with LTG-SJS/TEN,which may be a risk gene for LTG-SJS/TEN.HLA-B*1502,HLA-B*5801,HLA-B*1302 are not associated with LTG-MPE.
HLA-Blamotriginecutaneous adverse drug reactionsepilepsymeta-analysis
万方数据
维普
